QDEL — Quidel Corporation

Quidel Corporation (QDEL) is a medical devices company listed on NASDAQ. It is led by Brian J. Blaser, based in 9975 Summers Ridge Road, San Diego, CA, United States, 92121, with about 6,500 employees. QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

Latest reported QDEL revenue for 2025-09-28 was $699.9M. Net income was -$733.0M. Revenue was up 14.0% from 2025-06-29 to 2025-09-28. QDEL currently screens at market cap $895.3M.

Use this QDEL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the QDEL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the QDEL SEC filings page. Lician reads the product cache first so this HTML stays unique to Quidel Corporation even when a live quote feed is slow.